Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.37M Buy
79,378
+37,615
+90% +$1.4M 0.14% 125
2026
Q1
$1.47M Sell
41,763
-1,480
-3% -$65.1K 0.07% 184
2025
Q4
$2.12M Hold
43,243
0.09% 153
2025
Q3
$2.08M Sell
43,243
-11,792
-21% -$444K 0.1% 153
2025
Q2
$1.68M Buy
55,035
+7,465
+16% +$201K 0.08% 168
2025
Q1
$1.27M Buy
47,570
+4,015
+9% +$120K 0.07% 191
2024
Q4
$1.46M Sell
43,555
-14,670
-25% -$649K 0.08% 175
2024
Q3
$2.62M Sell
58,225
-25,275
-30% -$855K 0.17% 127
2024
Q2
$1.74M Hold
83,500
0.12% 142
2024
Q1
$1.1M Buy
83,500
+2,345
+3% +$25K 0.08% 185
2023
Q4
$909K Buy
81,155
+31,990
+65% +$379K 0.07% 189
2023
Q3
$707K Hold
49,165
0.06% 208
2023
Q2
$936K Sell
49,165
-6,800
-12% -$150K 0.07% 174
2023
Q1
$1.18M Hold
55,965
0.09% 157
2022
Q4
$826K Hold
55,965
0.07% 194
2022
Q3
$675K Hold
55,965
0.06% 209
2022
Q2
$407K Buy
+55,965
New +$378K 0.03% 279

Other funds holding HROW

Equitable Trust's HROW Position: Q2 2026 in Review

Equitable Trust increased its Harrow (HROW) stake by 90% in Q2 2026, buying an estimated $1.4M and bringing the position to 79,378 shares worth $3.37M. The position accounts for 0.14% of the portfolio, ranked #125.

Equitable Trust first reported a position in HROW in Q2 2022 and has held it in 17 quarters since. 223 funds tracked by Wall St. Rank hold HROW as of Q2 2026.

  • Equitable Trust held 79,378 shares of Harrow worth $3.37M as of Q2 2026.
  • Equitable Trust bought 37,615 Harrow shares in Q2 2026, an estimated $1.4M.
  • Harrow made up 0.14% of Equitable Trust's portfolio in Q2 2026, its #125 holding.
  • Equitable Trust first reported a position in Harrow in Q2 2022 and has held it in 17 quarters since.
  • 223 funds tracked by Wall St. Rank held Harrow as of Q2 2026.

Based on Equitable Trust's 13F filing for Q2 2026, filed 23 Jul 2026.